Etiologies and sequelae of extreme thrombocytosis in a large pediatric hospital
Thom, C. S.; Echevarria, E.; Osborne, A. D.; Carr, L.; Rubey, K.; Salazar, E.; Callaway, D.; Pawlowski, T.; Devine, M.; Kleinman, S.; Flibotte, J.; Lambert, M. P.
Show abstract
Extreme thrombocytosis (ET, platelet count >1000 x 103/ul) is an uncommon clinical finding 1. Primary ET is associated with myeloproliferative disorders, such as essential thrombocythemia 2. Secondary ET is more common and occurs in reaction to infection, inflammation, or iron deficiency. Bleeding and thrombotic complications more frequently arise in primary ET cases 1, but have been reported with secondary ET in adults 3. Etiologies and complications associated with ET in children are less well-defined, as prior pediatric studies have been relatively small or restricted to specialized patient populations 4,5. We aimed to characterize ET in a large, single-center pediatric cohort.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Platelet dysfunction in immune thrombocytopenia: finding clinical subsets with platelet phenotypes 93%
- Delayed-Phase Thrombocytopenia in Patients of Coronavirus Disease 2019 (COVID-19) 91%
- A validation study of the identification of haemophagocytic lymphohistiocytosis in England using population-based health data 90%
Similar papers in this journal
- Coagulation disorders in patients with severe hemophagocytic lymphohistiocytosis 93%
- Risk Factors For The Development Of Hospital-Acquired Pediatric Venous Thromboembolism: Dealing With Potentially Causal And Confounding Risk Factors Using Directed Acyclic Graph (Dag) Analysis 92%
- Sickle cell disease complications: prevalence and resource utilization 92%
Similar papers in this journal
- Platelet Factor 4 Antibody Persistence and Long-term Pathogenicity in Vaccine-induced Immune Thrombotic Thrombocytopenia 90%
- POmAb, an antibody targeting open prothrombin, results in anticoagulation without excessive bleeding in mice 90%
- Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia 90%
Similar papers in this journal
- Using Whole Genome Sequencing to Characterize Clinically Significant Blood Groups Among Healthy Older Australians 91%
- Antithrombotic Efficacy and Bleeding Risks of Vaccine-Induced Immune Thrombotic Thrombocytopenia Treatments 90%
- Sickle cell visualization in vivo in humans: microvascular occlusion formation and hemorheological indices 87%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.